跳至主要内容
临床试验/NCT03824860
NCT03824860已完成不适用

Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study

Dana-Farber Cancer Institute1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2019年8月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
Frequency of yoga practice by participants

研究概览

简要总结

This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy.

详细描述

This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy. The investigators will also explore participants' perceptions of acceptability and satisfaction with the yoga intervention. Lastly, the investigators will examine changes in chemotherapy-induced peripheral neuropathy severity, physical function, sleep-related impairment, fatigue, anxiety, depression, and pain following the eight-week yoga intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •≥18 years of age,
  • •self-report ≥ 4/10 worst chemotherapy-induced peripheral neuropathy pain over the past week,
  • •at least three months post neurotoxic chemotherapy completion
  • •signed informed consent,
  • •willingness to participate in all study activities
  • •speak/read English

排除标准

  • •prognosis of less than three months,
  • •documented peripheral neuropathy due to other causes (e.g., diabetes),
  • •planned receipt of neurotoxic chemotherapy during the study period,
  • •practice yoga >45 minutes per week over the past six months,
  • •diagnosis or documented recent history of significant psychiatric comorbidity (i.e., psychosis, suicidal ideation, or substance abuse)
  • •clinician deems that the patient is physically/functionally unable to participate in a yoga program

研究组 & 干预措施

Yoga Program

Experimental

Eight-weeks, therapist and self-guided yoga

干预措施: Yoga (Behavioral)

Treatment as usual

No Intervention

Control group participants will continue to receive usual care and symptom management strategies from clinicians during the study.

结局指标

主要结局

Frequency of yoga practice by participants

时间窗: From enrollment to end of treatment at 8 weeks.

Feasibility of participant adherence to the yoga intervention

Number of participants recruited to participate in the study

时间窗: From enrollment to end of treatment at 8 weeks.

Feasibility of participant recruitment to the study

Frequency of outcome assessments completed by participants.

时间窗: From enrollment to end of treatment at 8 weeks.

Feasibility of participant adherence to outcome assessments

次要结局

  • Fatigue assessed by Change in Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Physical Function(At the time of enrollment and at the end of treatment, at 8 weeks.)
  • Anxiety assessed by the "Change in Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety"(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Acceptability and Satisfaction with Participation in Yoga Intervention(At the end of treatment, 8 weeks after enrollment)
  • Pain Interference(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Worst Chemotherapy-Induced Peripheral Neuropathy Pain Intensity(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Chemotherapy-Induced Peripheral Neuropathy Severity(From enrollment to end of treatment at 8 weeks.At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Sleep-Related Impairment(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Depression assessed by Change in Patient Reported Outcomes Measurement Information System (PROMIS) Depression(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Knoerl, PhD, RN

Principal Investigator

Dana-Farber Cancer Institute

研究点 (1)

Loading locations...

相似试验

Yoga for Painful Chemotherapy-Induced Peripheral... | 临床试验